Vivoryon Therapeutics NV
AEX:VVY
Vivoryon Therapeutics NV
AEX:VVY
Price:
1.384
EUR
1.91%
Market Cap:
€41m
Vivoryon Therapeutics NV
Inventory
Last
Value
3 Years
3Y
CAGR
5 Years
5Y
CAGR
10 Years
10Y
CAGR
|
See Also
Vivoryon Therapeutics NV
Inventory Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Inventory | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Vivoryon Therapeutics NV
AEX:VVY
|
Inventory
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
BioNTech SE
NASDAQ:BNTX
|
Inventory
€283.3m
|
CAGR 3-Years
-17%
|
CAGR 5-Years
88%
|
CAGR 10-Years
N/A
|
|
|
CureVac NV
NASDAQ:CVAC
|
Inventory
€541k
|
CAGR 3-Years
-79%
|
CAGR 5-Years
-39%
|
CAGR 10-Years
N/A
|
|
|
Immatics NV
NASDAQ:IMTX
|
Inventory
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Biotest AG
XETRA:BIO
|
Inventory
€523.7m
|
CAGR 3-Years
27%
|
CAGR 5-Years
11%
|
CAGR 10-Years
8%
|
|
|
Formycon AG
XETRA:FYB
|
Inventory
€262k
|
CAGR 3-Years
8%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
-3%
|
|
No Stocks Found
Vivoryon Therapeutics NV
Glance View
The company is headquartered in Halle, Sachsen-Anhalt and currently employs 16 full-time employees. The company went IPO on 2014-10-27.
VVY
Intrinsic Value
Not Available
